Estás sin conexión — mostrando datos en caché
BibaMoney TVIJO AIOS NETWORK

Johnson & Johnson

JNJ · NYSE
Salud · Fabricantes de Medicamentos - General
$263.81 -1.42% today
—Capitalización de mercado
—P/U (TTM)
—Margen neto
—Ingresos / acción

Acerca de Johnson & Johnson

Johnson & Johnson is a healthcare holding company that researches, develops, manufactures, and sells products across the healthcare field. It operates through two segments: Innovative Medicine, which focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension, and MedTech, which includes products for interventional solutions, orthopaedics, surgery, and vision. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr.

Por qué es importante

Johnson & Johnson is one of the largest healthcare companies in the world by revenue and market capitalization, with a diversified portfolio spanning pharmaceuticals and medical devices. Its scale, broad product range, and long operating history make it a widely followed constituent of major market indices and a bellwether for the healthcare sector. Investors and traders monitor the company's segment performance, product pipeline, and litigation developments as part of assessing the broader drug manufacturing and medical technology landscape.

Sitio de la empresa ↗

Cómo investigamos a JNJ

Fundamentos como los anteriores alimentan nuestro filtro fundamental — aceleración de EPS, ROE y momentum∧calidad — la única clase de investigación que sobrevive al walk-forward en nuestras pruebas. No emitimos objetivos de precio ni llamadas de compra/venta: consulte /edge para ver con qué rigor (y con qué poca frecuencia) algo pasa. Esta página es datos de mercado e investigación, no es asesoramiento de inversión.

Data updated 18:00 UTC, 26 Oct 2026 · source: Financial Modeling Prep via Tvijo AIOS.